A ten-year review of progress in the treatment of non-small-cell lung cancer with gemcitabineNATALE, R.Lung cancer. 2005, Vol 50, pp s2-s4, issn 0169-5002, SUP1Article

Factors influencing exercise performance in thoracic cancerENGLAND, Ruth; MADDOCKS, Matthew; MANDERSON, Cathann et al.Respiratory medicine. 2012, Vol 106, Num 2, pp 294-299, issn 0954-6111, 6 p.Article

Standard therapy for the treatment of malignant pleural mesotheliomaVOGELZANG, Nicholas J.Lung cancer. 2005, Vol 50, pp s23-s24, issn 0169-5002, SUP1Article

Perspective on the development of new agents in thoracic cancersEINHORN, L.Lung cancer. 2005, Vol 50, pp s27-s28, issn 0169-5002, SUP1Article

The development of gemcitabine and carboplatin in the treatment of non-small-cell lung cancerCULLEN, M.Lung cancer. 2005, Vol 50, pp s5-s7, issn 0169-5002, SUP1Article

Advances in the treatment of second-line non-small-cell lung cancerHANNA, N.Lung cancer. 2005, Vol 50, pp s15-s17, issn 0169-5002, SUP1Article

Pemetrexed: a new cytotoxic agent in the development for first-line non-small-cell lung cancerSCAGLIOTTI, G. V.Lung cancer. 2005, Vol 50, pp s18-s19, issn 0169-5002, SUP1Article

Seeking new options for the treatment of small-cell lung cancerSOCINSKI, M. A.Lung cancer. 2005, Vol 50, pp s25-s26, issn 0169-5002, SUP1Article